Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -81.456% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CC(C)C(=O)N1CCN(c2ccc(NC(=S)NC(=O)c3cc4ccccc4o3)cc2)CC1
[b] CCOC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCN(CC)C2
Answer: b. CCOC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCN(CC)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCN(CC)C2
CCOC(=O)c1c(NC(=S)Nc2ccccc2)sc2c1CCN(CC)C2
ethyl 6-ethyl-2-(phenylcarbamothioylamino)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylate